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Characterizing Developmental Trajectories
and the Role of Neuropsychiatric Genetic Risk Variants
in Early-Onset Depression
Frances Rice, PhD; Lucy Riglin, PhD; Ajay K. Thapar, PhD, MD; Jon Heron, PhD; Richard Anney, PhD;
Michael C. O’Donovan, PhD, MD; Anita Thapar, PhD, MD
IMPORTANCE Depression often first manifests in adolescence. Thereafter, individual
trajectories vary substantially, but it is not knownwhat shapes depression trajectories in
youth. Adult studies suggest that genetic risk for schizophrenia, a psychiatric disorder with a
neurodevelopmental component, may contribute to an earlier onset of depression.
OBJECTIVE To test the hypothesis that there are distinct trajectories of depressive symptoms
and that genetic liability for neurodevelopmental psychiatric disorders (eg, schizophrenia,
attention deficit/hyperactivity disorder [ADHD]), as well as for major depressive disorder
(MDD), contribute to early-onset depression.
DESIGN, SETTING, AND PARTICIPANTS The Avon Longitudinal Study of Parents and Children is
an ongoing, prospective, longitudinal, population-based cohort that has been collecting data
since September 6, 1990, including data on 7543 adolescents with depressive symptoms at
multiple time points. The present study was conducted between November 10, 2017, and
August 14, 2018.
MAIN OUTCOMES ANDMEASURES Trajectories based on self-reported depressive symptoms
dichotomized by the clinical cutpoint; MDD, schizophrenia, and ADHD polygenic risk score
(PRS) were predictors.
RESULTS In 7543 adolescents with depression data onmore than 1 assessment point
between amean (SD) age of 10.64 (0.25) years and 18.65 (0.49) years (3568 [47.3%]male;
3975 [52.7%] female), 3 trajectory classes were identified: persistently low (73.7%),
later-adolescence onset (17.3%), and early-adolescence onset (9.0%). The later-adolescence–
onset class was associated with MDD genetic risk only (MDD PRS: odds ratio [OR], 1.27; 95%
CI, 1.09-1.48; P = .003). The early-adolescence–onset class was also associated with MDD
genetic risk (MDD PRS: OR, 1.24; 95% CI, 1.06-1.46; P = .007) but additionally with genetic
risk for neurodevelopmental disorders (schizophrenia PRS: OR, 1.22; 95% CI, 1.04-1.43;
P = .01; ADHD PRS: OR, 1.32; 95% CI, 1.13-1.54; P < .001) and childhood ADHD (χ21 = 6.837;
P = .009) and neurodevelopmental traits (pragmatic language difficulties: OR, 1.31; P = .004;
social communication difficulties: OR, 0.68; P < .001).
CONCLUSIONS AND RELEVANCE The findings of this study appear to demonstrate evidence of
distinct depressive trajectories, primarily distinguished by age at onset. Themore typical
depression trajectory with onset of clinically significant symptoms at age 16 years was
associated with MDD genetic risk. The less-common depression trajectory, with a very early
onset, was particularly associated with ADHD and schizophrenia genetic risk and,
phenotypically, with childhood ADHD and neurodevelopmental traits. Findings are consistent
with emerging evidence for a neurodevelopmental component in some cases of depression
and suggest that the presence of this component may bemore likely when the onset of
depression is very early.
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M ajor depressive disorder (MDD) is themost commonmentaldisorderandaleadingcauseofdisability1;evensubthreshold depressive symptoms are associated
with functional impairment and future mental health
problems.2,3Depressionoften firstmanifests inadolescence4-6
and, thereafter, individual trajectories of depressive symp-
tomsvary substantially.7A familyhistoryofdepressionandan
earlyageatonsetareeachassociatedwithamorechronicsymp-
tom course in adults with MDD,8-10 but it is not known what
shapes early depression trajectories in youth.
Depressionhasacomplexmultifactorialsetofcauses, includ-
ingamoderateheritablecomponent.4,11,12Longitudinalandfam-
ily studies show continuity between both adolescence-onset
depressive disorder and symptoms with depression in adult
life,buttherearealsodevelopmentaldifferencesbetweendepres-
sion in children, adolescents, andadults.4 For instance, clinical
follow-upstudiesofveryearly-onsetdepression (averageageat
onset,10.7years)reporthighratesofheterotypiccontinuity,where
depression is often followed by a different type of clinical
disorder.13-15Twinstudiesalsoshowdifferencesinthegeneticset
ofcausesofveryearly-onsetdepressivesymptomscomparedwith
those arising inmid- to late adolescence.16-18
At the molecular level, a recent genome-wide association
study of adults withMDD found evidence of differences in the
geneticarchitectureofdepressionwherearelativelyearlyageat
onset (beforethemedianageatonsetof27years)wasassociated
withgenetic liabilitytoschizophrenia,anassociationnotseenfor
later-onsetdepression,whichwas insteadassociatedwithMDD
riskalleles.19 Similar findingshavebeen reported for emotional
problems(symptomsofdepressionandanxiety)inthatemotional
problems inchildhoodwereassociatedwith schizophrenia risk
alleles, but in adult life they were additionally associated with
MDDgenetic risk.20Theassociationofschizophrenia riskalleles
withchildhoodemotionalproblemswasparticularlypronounced
in thosewith emotional problems inboth childhoodandadult-
hood,suggestingthatpersistentemotionalsymptomsbeginning
earlymay drive the associationwith schizophrenia risk alleles.
Asschizophreniageneticriskisthoughttoinvolveanearlyneuro-
developmental component,21,22 the roleofgenetic risk forother
neurodevelopmentaldisorders inearly-onsetdepressionmaybe
importanttoconsider. Inparticular,geneticriskforADHD,acom-
mon childhood-onset neurodevelopmental disorder, may be
important inearly-onsetdepressionbecausecross-sectionaland
longitudinalcohortstudiesshowheightenedratesofdepression
in children with ADHD,23-25 which may be partly due to the
strong genetic correlation between ADHD and depression
(rg = 0.424).26,27
Herein, we test the contribution of neuropsychiatric
disorder genetic risk variants, specifically genetic liability to
MDD, schizophrenia, and ADHD, to early depression trajecto-
ries.SchizophreniaandADHDwereselected inadditiontoMDD
as they showmoderate tohighgenetic correlationswithmajor
depression,27 there isevidence linkingschizophreniapolygenic
risk score (PRS) to early-onset depression,19,20 and epidemio-
logic and clinical evidence15,23-25 thatADHDmaybe an impor-
tant antecedent of depression.
Estimates of genetic liability to the disorders in the
form of PRSs were derived from risk alleles defined in the
largest available genome-wide association study of those
disorders.26,28,29 We did not have a specific hypothesis for
bipolar disorder genetic risk because existing studies report-
ing conflicting results about the phenotypic association be-
tweenearly-onset depressionandbipolar disorder,13,15,30with
little evidence that this association is stronger for early-onset
depression.Bipolardisorderalsodiffers fromADHDandschizo-
phrenia in that evidence suggests that bipolar disorder is less
neurodevelopmental in origin.21,22 However, for complete-
ness, we included bipolar PRSs in our analyses (eTable 2A in
theSupplement).Wehypothesized thatADHDandschizophre-
nia genetic risk would show an association with early-onset
depression and that depression genetic risk would be associ-
ated with depression with an onset later in adolescence.
Methods
TheAvonLongitudinalStudyofParentsandChildren (ALSPAC)
is an ongoing, population-based, prospective, longitudinal UK
birth cohort.31,32Data collectionbeganSeptember6, 1990.The
enrolledcoresampleconsistedof 14541pregnantwomenliving
in Avon, England, with expected delivery dates between April
1, 1991, andDecember 31, 1992.Of thesebirths, 13988 children
were alive at 1 year.Anadditional 713 childrenwhowouldhave
been eligible but whosemothers did not choose to participate
duringpregnancywere enrolled after age 7years, giving a total
sample of 14 701 children alive at 1 year. Thepresent studywas
conducted betweenNovember 10, 2017, andAugust 14, 2018.
Ethical approval for the study was obtained from the
ALSPAC Ethics and Law Committee and the local research
ethics committees. All participants providedwritten informed
consent; there was no financial compensation.
Thestudywebsite containsdetails of all of thedata that are
available througha fully searchabledatadictionary.33For fami-
lies with multiple births, we included the oldest sibling. Indi-
vidualswere includedinanalyseswhendataontheprimaryout-
comeofdepressive symptomswereavailable for at least 2 time
points (n = 7543). The sample mean age (SD) was 10.64 (0.25)
years at baseline and 18.65 (0.49) years at the final time point.
Key Points
Question Do neuropsychiatric disorder genetic risk variants
influence developmental trajectories of depression in youth?
Findings In this population-based study including 7543
adolescents, distinct depression trajectory classes were identified.
A later-adolescence–onset class (17.3% of the sample) showed a
typical depression trajectory and was associated with major
depressive disorder risk alleles, and an early-adolescence–onset
class (9.0%) showed clinically significant symptoms at age 12 years
and was associated with schizophrenia and attention-deficit
hyperactivity disorder genetic risk, childhood attention-deficit
hyperactivity disorder, and neurodevelopmental traits.
Meaning Depression in youth is heterogeneous; findings are
consistent with emerging evidence for a neurodevelopmental
component to some cases of depression and that this component
is more likely when onset is very early.
Research Original Investigation Developmental Trajectories and Neuropsychiatric Genetic Risk Variants in Early-Onset Depression
E2 JAMAPsychiatry Published online October 14, 2018 (Reprinted) jamapsychiatry.com
Downloaded From:  by a University of Bristol User  on 10/30/2018
Thenumbersof individualswithdataavailableatdifferenttimes
are shown in the eFigure in the Supplement.
Depressive symptoms were reported by the young per-
son at 6 time points (ages 10.5, 12.5, 13.5, 16.5, 17.5, and 18.5
years) on the short Mood and Feelings Questionnaire. This is
awell-validated symptomchecklist34-36 that includes 13 items
about mood symptoms during the past 2 weeks (rated 0, not
true; 1, sometimes true; or 2, true; score range, 0-26). Scores
above 11 represent clinically significant symptoms,34,36 andwe
analyzed individuals scoring above and below this level to
examine trajectories of clinically significant symptoms.
PolygenicriskscoresforMDD,schizophrenia,andADHDwere
generated in study individuals as the standardizedmeannum-
ber of disorder risk alleles in approximate linkage equilibrium
(R2<0.20), weighted by genome-wide association study allele
effect size derived from data of imputed autosomal single-
nucleotidepolymorphisms.All analyseswereperformedusing
Stata, version 13.0 (StataCorp) to implement the PLINK toolset
(http://zzz.bwh.harvard.edu/plink/; code is available at https:
//github.com/ricanney/stata). In brief, best-guess genotype
underwent additional marker and individual quality control.
Individuals were excluded on the basis of excessive
heterozygosity (>4SDs fromsamplemean), relatedness (>3SDs
fromsamplemean), andgenotypemissingness (>2%).Markers
wereexcluded if theywererare (minorallelecount<5),hadhigh
levels of missingness (>2%), or deviated fromHardy-Weinberg
equilibrium(P ≤ 10−10)or fromreferenceminorallele frequency
(>10%) (eMethods in the Supplement).
Scores were derived fromMDD, ADHD, and schizophrenia
weights for 152536, 103041, and27336single-nucleotidepoly-
morphisms,respectively.Riskallelesweredefinedasthoseasso-
ciatedwithcase status in themost recentPsychiatricGenomics
Consortium analyses of MDD, ADHD, and schizophrenia at a
threshold of P < .50 for depression and ADHD and P < .05 for
schizophrenia,asthesethresholdsmaximallycapturephenotypic
variance.26-29,37Genome-wideassociationstudydiscoverysample
sizes were 130664 cases and 330470 controls forMDD, 20 183
casesand35 191controls forADHD,and35476casesand46839
controls for schizophrenia. All PRSswere standardized prior to
analysis sooddsratios (ORs) represent 1SDchange (eTable2A in
theSupplementforbipolarPRSs).Phenotypicmeasuresofneuro-
developmental problems (DSM-IV38 diagnoses of childhood
ADHD,socialcommunicationproblems,andpragmatic language
difficulties at age 7 years), psychotic experiences (ages 12 and
17years), familyhistoryofseveredepressionandschizophrenia,
and maternal educational level were used (eMethods in the
Supplement).
Statistical Analysis
Wecharacterizeddepression trajectoriesof symptomsdichoto-
mized by clinical cutpoint (n = 7543) using latent class growth
analysis inMplus,version8.39Thisanalysis isaprobability-based
techniqueused to identify anoptimumnumber of distinct pat-
terns (classes)ofgrowth (change) in the longitudinaldepression
scores of individuals.40Modelswere runwith increasing num-
bersofclasses,startingwitha1-classsolutionspecifyingbothlin-
ear andquadratic changewith 500 randomstarting values and
50optimizations.Residualvarianceswereallowedtovaryacross
measurementpoints.Amaximumlikelihoodparameterestima-
tor forwhich SEs are robust to nonnormalitywas used.
Toexamineassociationswithcategoricalvariables (eg, sex),
theDCATauxiliaryoption inMPluswasused.Abias-free,3-step
approachinMPlus(R3STEP)estimatedtheassociationsbetween
continuoushypothesizedpredictor variables (PRSs) and trajec-
tory class.41-43Model selectionwas informed bymodel fit indi-
ces and interpretability as recommended.44 Full information
maximumlikelihoodestimationwasusedinMPlusandincluded
all individualswithmorethan1depressionassessment inanaly-
ses(eTable1 intheSupplement).FortestsofPRSassociationwith
trajectory class, we reran analyses using inverse probability
weighting45 to address anypotential bias causedbyparticipant
dropout. The pattern of results was similar (eTable 3 in the
Supplement).
Results
Depression Symptom Trajectories
A3-class trajectorymodel provided the best fit to the data and
results that were most readily interpretable (eTable 1 and
Figure. Developmental Trajectories of Depressive Symptoms
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eAppendix 1 in the Supplement). The Figure shows the 3
distincttrajectoryclasses:apersistently lowclass(73.7%),a later-
adolescence–onset class (17.3%), and an early-adolescence–
onset class (9.0%). In the early-adolescence–onset class, the
probability of clinically significant depression was first
elevated (as indicated by a probability of clinically significant
depression symptoms of 0.44) at age 12.5 years, which rose to
0.52at 13.5years. In the later-adolescence–onsetclass, theprob-
ability of clinically significant depression (probability, 0.47)
was first elevated at age 16.5 years and rose at 17.5 years (prob-
ability, 0.57). Both elevated trajectories were associated
with a diagnosis of MDD (assessed by the Clinical Interview
Schedule–Revised46 at age 17.5 years) providing validation of
the trajectory classes (later-adolescence onset, 34.4%; early-
adolescence onset, 22.8%; low level, 1.5%; overall difference,
χ22 = 193.70;P = .001).Theestimatedproportionof femaleswas
45.8% in the low-level class and was higher, but did not differ
significantly,betweentheearly-adolescence– (74.3%)and later-
adolescence– (73.2%) onset classes (Table 1).
Neuropsychiatric PRS and Trajectory Class
As reported in Table 2, the later-adolescence–onset class was
associated onlywith higherMDDPRS (OR, 1.27; 95%CI, 1.09-
1.48; P = .003). The early-adolescence–onset class was asso-
ciatedwith higher PRSs for ADHD (OR, 1.32; 95%CI, 1.13-1.54;
P < .001), schizophrenia (OR, 1.22; 95%CI, 1.04-1.43;P = .01),
andMDD (OR, 1.24; 95%CI, 1.06-1.46;P = .007). Post hoc,we
examined the association with all 3 psychiatric PRSs and tra-
jectory class to examinewhichPRS contributedmost strongly
(Table2).Asexpected, thePRSswerecorrelated (eTable2Band
C in the Supplement).
Multivariate analysis showed that the strongest associa-
tionwith the early-adolescence–onset class was observed for
ADHD PRS, the association with schizophrenia PRS was re-
tained, and the associationwithMDDPRSbecamenonsignifi-
cant (Table2).Results for the later-adolescence–onset class re-
mained the same.Comparing theearly- and later-onset classes
showed significant differences (MDD PRS: OR, 1.13; 95% CI,
0.88-1.46;P = .33; schizophrenia PRS:OR,0.78; 95%CI, 0.60-
1.01; P = .08; and ADHD PRS: OR, 0.71; 95% CI, 0.55-0.92;
P = .009). Bipolar PRS was not associated with trajectory
classes (eTable 2A in the Supplement). Including ancestry-
derived principal components did not alter the results
(eAppendix 2 in the Supplement).
We tested whether the trajectory classes differed pheno-
typicallyontraits conceptually relatedtoADHDPRS(childhood
ADHDandneurodevelopmental traits) and schizophreniaPRS
(psychotic experiences). For childhood neurodevelopmental
Table 1. Phenotypic AssociationsWith Trajectory Classa
Variable
Onset, OR (95% CI)
Difference Between Early- and
Later-Adolescence–Onset Classesb
Early
Adolescence P Value
Later
Adolescence P Value
χ21 or
OR (95% CI) P Value
Sex, % 74.3 <.001 73.2 <.001 χ 21 = 0.015 .90
Maternal education, completed A-levels, %c 39.1 .01 34.9 .001 χ 21 = 0.707 .44
Childhood ADHD, % 6.3 .008 0.9 .37 χ 21 = 6.837 .009
Pragmatic language difficultiesd 0.63 (0.55-0.71) <.001 0.82 (0.72-0.94) .006 OR, 1.31 .004
χ 21 = 11.709 .001 (for Cutpoint)
Social communication difficultiese 1.50 (1.34-1.68) <.001 1.01 (0.87-1.18) .86 OR, 0.68 <.001
χ 21 = 18.819 .001 (for Cutpoint)
Psychotic experiences
12 y 1.47 (1.35-1.61) <.001 0.89 (0.64-1.22) .46 OR, 0.60 .003
17 y 1.57 (1.36-1.80) <.001 1.54 (1.33-1.79) <.001 OR, 0.99 .74
Abbreviations: ADHD, attention deficit/hyperactivity disorder; OR, odds ratio.
a Continuous scores are standardized so that ORs are for 1-SD increase. Low-risk
group was the reference group except for tests of comparison between
early-adolescence– and later-adolescence–onset groups where the
early-adolescence–onset group was the reference group.
b χ2 Tests of difference for social communication and pragmatic language
difficulties used the established clinical cut-points for identifying problems
(eAppendix in the Supplement). The OR values represent the difference
between the ORs in the preceding columns for later-adolescence onset vs
early-adolescence onset.
c A-level education is equivalent to high school diploma in the United States
d Lower scores represent more difficulties.
e Higher scores represent more problems.
Table 2. Associations of Polygenic Risk ScoresWith Trajectory Classes
Association
Onset, OR (95% CI)
Early Adolescence P Value Later Adolescence P Value
Univariate
MDD PRS 1.24 (1.06-1.46) .007 1.27 (1.09-1.48) .003
Schizophrenia PRS 1.22 (1.04-1.43) .01 .95 (0.82-1.11) .56
ADHD PRS 1.32 (1.13-1.54) <.001 .94 (0.80-1.11) .48
Multivariate
MDD PRS 1.16 (0.98-1.36) .09 1.31 (1.12-1.53) .001
Schizophrenia PRS 1.19 (1.01-1.41) .04 .93 (0.79-1.10) .39
ADHD PRS 1.27 (1.08-1.50) .003 .90 (0.76-1.07) .23
Abbreviations: ADHD, attention
deficit/hyperactivity disorder; MDD,
major depressive disorder; OR, odds
ratio; PRS, polygenic risk score.
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traits, there isevidencethat thesetraitsareassociatedwithboth
ADHDandADHDPRS47,48; for psychotic experiences, there is
inconsistent evidence that these experiences are linked with
psychosis andschizophreniaPRSs49,50 (Table 1). Individuals in
theearly-adolescence–onsetclasshadhigher ratesofchildhood
ADHD(6.3%) than the later-adolescence–onset (0.9%)and low
(1.7%) classes andmore social communication and pragmatic
languageproblems(Table1).Proportionsscoringabovethestan-
dard cutpointswereearlyonset, 20.7%; later onset, 4.2%; and
lowlevel,5.8%forsocialcommunicationandearlyonset, 13.3%;
later onset, 2.1%; and low level, 1.4% for pragmatic language.
These differences distinguished the early-adolescence– and
later-adolescence–onset classes (Table 2). For psychotic expe-
riences, thesedifferencesdistinguishedtheearly-adolescence–
and later-adolescence–onset classes only at age 12 years.
Discussion
This study identified variation in thedevelopmental trajecto-
riesofdepression fromchildhood toearly adult life, andmore-
over, that this variation is partly attributable to MDD, schizo-
phrenia, andADHD risk alleles.We foundevidence of distinct
depressive trajectories primarily distinguished by age at on-
set.We found that themore common, typical developmental
trajectory,with onset after puberty andpersistence into early
adulthood,6,51 was associated with elevated genetic risk for
depression indexed by MDD PRS. In contrast, we found that
depressive symptomsdefined by a very early onset (by age 12
years) were associated with all neuropsychiatric genetic risk
scores assessed, with multivariate analysis showing that the
association was strongest for ADHD PRS.
Phenotypically, childhood neurodevelopmental difficul-
ties (ADHD,pragmatic language,andsocial communicationdif-
ficulties)differentiated thedepression trajectories thatwereel-
evated only in the early-adolescence–onset group with rates
increasedby5- to 7-fold in the early-adolescence–onset group.
Psychotic experiences differentiated the groups only at age 12
years. This discrepancymaybedrivenbydepressive symptom
differences between the groups at age 12 years (Figure) given
the reported association between psychotic experiences and
depression and an inconsistent association with psychotic
experiences and schizophrenia PRS.49,50 The findings are con-
sistent with a growing body of literature showing that depres-
sion has heterogeneous causes partly indexed by age at onset.
In particular, studies of adult MDD and symptoms measured
continuously inpopulation-basedsamples illustrate thata rela-
tivelyearlieronset ismorestronglyassociatedwithschizophre-
nia polygenic risk.19,20,52 We found an additional contribution
fromADHD PRSs.
The implication of those results is that early- and later-
adolescence-onset depression differ to some extent with
respect to the risk factors involved and that the earlier-onset
disorder is more strongly influenced by neurodevelopmental
factors than depressionwith amore typical onset in later ado-
lescence or early adulthood. This finding is consistent with a
number of observations fromepidemiologic, family, and clini-
cal studies. First, several family and clinical follow-up studies
suggest that childhood-onset depressionmight differ etiologi-
cally from adolescent-onset depression.53-56 Second, the
epidemiologic factors associatedwithveryearly-onsetdepres-
sion differ from those of depression with onset in midadoles-
cence to late adolescence in the sex ratio of affected individu-
als and long-term psychiatric outcomes.13,57 Third,
neurodevelopmental difficulties, including speechabnormali-
tiesandpoormotorskills, areparticularlyassociatedwithearly-
onset rather thanadolescent- or adult-onsetdepression.15,58,59
Fourth, substantial clinical evidence shows that childrenwith
ADHD, a common neurodevelopmental disorder, are at
elevated risk of subsequent depressive symptoms, suicide
attempt, and emotional problems in adult life.25,60-63
Theory suggests neurodevelopmental difficulties as one
route to emotional disturbance through the repeated experi-
enceof academic failure andpeer rejection,64 althoughADHD
anddepressionmay also be associated owing to common risk
factors.65 A clinical issue is that the response to antidepres-
sant medication66-69 in youth is not as good as it is in adults
and evidence suggests the response to tricyclic antidepres-
santsmaydiffer inprepubertalvspostpubertaldepression.One
possibility is thatmoreneurodevelopmentaldepressionshows
a different type of treatment response.
Thepresent study indicates that genetic risk forADHDand
schizophrenia inthegeneralpopulation isassociatedwithaper-
sistent, early-onset trajectory of depressive symptoms. Such
effects could operate through overlapping biological path-
waysaswell as evocativegene-environment correlationwhere
genetic factors influence traits that then affect environmental
exposures (eg, social exclusion) associated with depression.
Irritability,which is common in childrenwithADHDandother
neurodevelopmental disorders, is indexed by genetic risk for
ADHD in youth70 and has been shown to increase risk for later
depression,71,72maybe a potential route throughwhichADHD
genetic risk increases the likelihood ofmood problems.
Amongthosewithearly-onsetdepression,wedidnot iden-
tify the equal sex ratio of affectedmales and females that has
often been reported when depression onset is very early.4,73
This findingwas somewhat surprising, andseveral factorsmay
have contributed to it. First, some research suggests that de-
pression is particularly likely in females with neurodevelop-
mental disorders, which may imply that high neurodevelop-
mental risk is more likely to manifest as mood disorder in
females.24,48,74 Second,while it is generally accepted that self-
reports of adolescentmood (as used in the present study) are
reliable, children with neurodevelopmental disorders, pre-
dominatelyboys,mayunderreport theirmoodsymptomscom-
pared with typically developing children.75 This reporting
difference raises the possibility that the reliance on self-
reported mood necessary in the present study due to re-
peated longitudinal assessments (see below) may mean that
some individuals at high neurodevelopmental risk may have
beenmisclassified. Finally, PRSs alone are unlikely to be able
to reliably classify children’s risk of developingdifferent types
of depression trajectories. However, collectively, results con-
verge to suggest thatneurodevelopmentalphenotypes (ADHD,
as well as social communication and pragmatic language dif-
ficulties) and neurodevelopmental genetic risk indicate a
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greater probability of an early-onset depression trajectory.
Phenotypic childhood neurodevelopmental problems were
markedly increased in the early-adolescence–onset group (by
5- to 7-fold) comparedwith the typical depression trajectory.
Studieswith follow-up further intoadult lifewill help to clarify
the adult mental health outcomes of these groups.
Strengths and Limitations
Strengthsof this study include the repeated-measures longitu-
dinal design where depression was assessed using the same
measure and informant. Typically, longitudinal studies in-
cludechanges inmeasurement and informant, inparticular, as
children age, the informant tends to change from theparent to
the young person. This variation provides a challenge to stud-
iesseekingtoexaminethedevelopmentofsymptomsover time
because changes ofmeasurement and informant can affect re-
sults. This invariance of measurement over time is a strength.
One limitation of our investigation is that, likemany lon-
gitudinal studies, nonrandomattritionoccurs inALSPACover
time (eAppendix 2 in the Supplement). This nonrandom loss
of participants is likely to result in conservative estimates of
the prevalence of the elevated depression trajectory groups.
We used a number of approaches to deal with missing data,
including full information maximum likelihood in trajectory
modeling and inverse probability weighting for tests of asso-
ciation. The pattern of results was replicated using inverse
probabilityweighting.Nonetheless, themissingdata assump-
tion made in our analyses is that there are not systematic
differences between participants who do and do not provide
trajectorydata andmembership in the sample after condition-
ing on the other variables in themodel (eg, PRS and variables
included in the inverse probability weighting analysis).
Depression was assessed using self-reported question-
naires rather thanclinical assessment.Nonetheless, subthresh-
old symptoms are associated with impairment and subse-
quentMDD.2-4 Itwasnotpossible to investigate rates ofmania
or bipolar disorder in the trajectory groups. However, evi-
dence is inconsistent on the link with early-onset depression
andbipolar disorder.13,15,30 The follow-upperiod in this study
was limited to early adult life. A final limitation is that PRSs
are weak predictors and explain only a small to modest pro-
portion of phenotypic variance as they do in the present
article. However, they provide a useful biological indicator of
genetic liability.76
Conclusions
The findings of this study suggest etiologically distinct trajec-
tories of depressive symptoms in youth dependent on age at
onset. The findings also show that neurodevelopmental
genetic risk contributes to very early-onset depression.
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